Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001144204-13-031916

Options or other derivatives

  • President and CEO acquired 1,225,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Carpenter George C IV · President and CEO

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2013-05-23 Grant or award : show line 1 in the form Option to Purchase +1,200,000 1,200,000 D
2013-05-23 Grant or award : show line 2 in the form Option to Purchase +25,000 25,000 D
Loading xslF345X03/v346294_4.xml…